Section 1: Summary of the Opportunity

Evident Ventures is a new $50M seed/early-growth stage venture capital fund launched by Iñaki Berenguer and Rika Christanto — two GPs who previously worked together at McKinsey and as partners at LifeX Ventures (a $100M VC fund investing in AI x Health & Science). The fund targets 25–30 "breakout AI companies" across Europe and the US, with global flexibility.

The GPs position themselves as "tech founders and investors" with complementary backgrounds: Berenguer is a 6x founder/CEO with exits including CoverWallet (acquired by Aon) and Pixable (acquired by SingTel), plus 150+ angel investments including Flywire (NASDAQ: FLYW, IPO at $5B). Christanto is a 3x founder/CXO with Ontruck (backed by Atomico), Idoven (backed by Insight Partners, TIME's Top Health Tech), and Veritrans (acquired by Gojek).

Key Value Proposition: Access to two operator-VCs with deep European and US networks, a proven shared GP portfolio showing 1.5x–5x MOICs on AI companies (2022–2025), and positioning at the intersection of the AI agent wave and large industry verticals.

Section 2: Market Opportunity Analysis

AI Venture Capital Market

Evident Ventures' thesis centers on the expanding AI opportunity — from the $1T software market to the $50T+ labor market — as AI evolves through three waves: GenAI (creation), Reasoning (decision-making), and Agents (labor automation).

Market Claims (Deck):

• AI is expanding from $1T software TAM to $5T decision TAM to $50T+ labor TAM
• NVIDIA sees $1T+ demand through 2027 for AI infrastructure
• AI model costs collapsing — software development costs fell 91% in 2025
• AI task capability doubling every 6 months (Kleiner Perkins 2026)
• Top AI startups reach $100M ARR in 4 years vs. 7 for SaaS (Stripe data)
• Top AI startups are 4–5x more capital-efficient ($1.13M ARR/FTE in Year 1)

Independent Validation:

• ✅ European VC funding rose ~9% YoY to $58B in 2025, with AI emerging as leading sector for first time (Crunchbase, Jan 2026)
• ✅ NVIDIA's $1T demand claim is directionally supported by $114B quarterly data center capex by hyperscalers
• ✅ AI M&A more than doubled in Q2 2025 vs. five-year average (177 global deals) — creating earlier exit windows for seed investors
• ✅ Stripe's "Indexing the AI Economy 2025" report validates faster time-to-$100M-ARR for AI companies
• ⚠️ AI infrastructure spending may be overheated — circular funding dynamics and extreme valuations (Palantir at 230x P/E) raise bubble concerns
• ⚠️ The $50T "labor TAM" is aspirational and decades away from being addressable by venture-backed AI companies

Market Headwinds:

• AI application layer faces an "application crunch" as model companies raise inference costs and margins compress
• European VC ecosystem still lags US: fewer mega-exits, smaller fund ecosystem, brain drain to US
• Seed-stage valuations in AI are elevated — median pre-money at ~$15.8M with significant variance
• Potential regulatory headwinds from EU AI Act implementation

TAM for Fund Strategy:

• AI-focused seed VC globally: ~$10–15B annually (growing)
• European seed AI deals: ~$3–5B annually
• Evident Ventures' share: $50M fund / 3-year deployment = ~$17M/year deployed across 8–10 deals/year
• Conclusion: Fund size is well-calibrated for seed stage. No capital deployment constraints.

Section 3: SWOT Analysis

Strengths

• Complementary founder-operator GPs with genuine exits. Berenguer: CoverWallet acquired by Aon (confirmed Jan 2020, ~$28M raised, ~$300M claim in deck), Pixable acquired by SingTel ($30M). Christanto: Ontruck co-founder (€17M+ raised, backed by Atomico), Veritrans (acquired by Gojek). Together they've raised $100M+ as founders — they understand the founder journey from zero to exit.
• Exceptional angel track record with verified unicorn picks. Berenguer's first-investor-in-Flywire claim is verified (Flywire IPO'd at ~$5B in 2021). Deck claims 110x MOIC on Flywire, 26x on an iBuyer, 13x on Cabify. Multiple exits to Apple, Coinbase, Hippocratic AI. 150+ angel investments over 2010–2025 provides deep pattern recognition.
• Strong shared GP portfolio (2022–2025) with blue-chip co-investors. 10 portfolio companies showing 1.5x–5.0x MOICs. Co-investors include Lightspeed, Bessemer, NEA, Eclipse, Green Oaks, Wellington — Tier 1 validation. Stack AI (5.0x, 245% IRR), MITO AI (3.6x, co-invested with Lightspeed), Sully AI (3.5x).
• Deep institutional network across McKinsey, Harvard, MIT, Cambridge. Both GPs have elite academic credentials (Berenguer: PhD Cambridge, MBA MIT, Fulbright Scholar Columbia; Christanto: BA/MBA Harvard). McKinsey alumni network is one of the most powerful in global business.
• 4% GP commitment ($2M) signals strong alignment. Well above the 1–2% minimum typically seen in first-time funds. Meaningful skin in the game.

Weaknesses

• First-time fund as "Evident Ventures" — no audited track record under this entity. The shared GP portfolio (2022–2025) was built at LifeX Ventures and as personal angel investments. Evident Ventures Fund I is a new entity. LPs are betting on the GP team, not a proven fund machine.
• CoverWallet acquisition value may be overstated. Deck claims "$1B+ in premium revenue and acquired for $300M in 4 years." However, AlleyWatch (2019) reports CoverWallet raised only $28.3M total. Aon acquisition price was never publicly disclosed — the $300M figure appears to be a deck claim, not an independently verified number. "Premium revenue" (insurance premiums processed) is a top-line vanity metric, not actual company revenue.
• Small fund ($50M) limits operational bandwidth. 2% management fee on $50M = $1M/year. For a 2-GP team with overhead, this is lean. May strain operational capacity or force GPs to rely on external admin support.
• European focus creates inherent exit friction. While the fund targets US + Europe, the GPs' strongest networks are European. European seed exits are historically smaller and slower than US peers. The deck acknowledges this but doesn't quantify the impact.
• Shared GP portfolio MOICs are paper gains. The 1.5x–5.0x MOICs shown are all unrealized (based on last-round valuations). No DPI demonstrated. In a market correction, these multiples could compress significantly.

Opportunities

• AI agent wave creates massive new market for seed investment. The deck's thesis that the most exciting agentic AI companies are still emerging is well-supported. Seed-stage is the optimal entry point for power-law returns in a nascent market.
• European AI ecosystem is maturing rapidly. $58B in European VC in 2025 (+9% YoY), with AI leading for the first time. ElevenLabs ($11B), Mistral ($7B+), and other European AI breakouts prove the thesis that not all AI winners emerge from Silicon Valley.
• Barbell portfolio construction (seed + early growth co-invest) captures alpha at two points. Leading seed rounds for 5–15% ownership + co-investing in later rounds with Tier 1 funds via SPVs is a smart structure that allows fund-returner exposure without excessive concentration risk.
• LP direct investing fee-free is a genuine LP benefit. Allows LPs to size up their best-performing positions without paying carry — differentiator vs. most seed funds.

Threats

• AI bubble risk is real and acknowledged. If AI infrastructure spending proves overheated and application-layer companies can't generate revenue at scale, seed valuations will compress. The fund's own deck shows awareness of this but doesn't provide quantitative downside scenarios.
• Competition for AI seed deals is intense. Established AI seed funds (AI Seed Fund, Lightspeed Scout, Sequoia Scout, a16z Seed) have deeper pockets and stronger brand. First-time fund brand recognition is a disadvantage in competitive deal processes.
• Key person risk. Two-GP fund means both principals are critical. If either GP leaves, the fund's network advantage and investment strategy would be materially impaired.
• 1.3x hurdle is low by institutional standards. Compared to the industry standard 8% IRR hurdle (or 1.8x+ over a 10-year fund), the 1.3x hurdle means carry kicks in early. This is less LP-protective than standard terms.

Section 4: Competitive Landscape

Direct Competitors (AI-Focused Seed/Early-Stage Funds, Europe + US)

Positioning Analysis

Unique Position: Evident Ventures differentiates through (1) both GPs being serial tech founders with exits — not career VCs, (2) deep cross-Atlantic network spanning Europe and US tech/academic ecosystems, (3) specific AI x vertical industry thesis (fintech, robotics, semiconductors, compute) rather than generalist AI.

Key Differentiator (Claimed vs. Validated):

Competitive Intensity: HIGH. AI seed investing is currently the most competitive segment of venture capital. Multiple well-capitalized funds with stronger brands and longer track records compete for the same deals. Evident's edge is network-driven (European founder networks, McKinsey/Harvard/MIT alumni) rather than brand or platform-driven.

Section 5: Risk Analysis

Red Flags Summary:

1. 🔴 CoverWallet exit value unverifiable — $300M claim not supported by public sources; AlleyWatch reports only $28.3M raised
2. 🔴 All GP portfolio returns are paper — zero realized returns (DPI = 0x)
3. 🟡 Low hurdle rate (1.3x) — carry kicks in before meaningful absolute return to LPs
4. 🟡 First-time independent fund — GP chemistry proven at LifeX but independent operation untested

Section 6: Team Evaluation

Key Strengths:

• Operator-investor hybrid. Both GPs have built companies, raised capital, hired teams, and navigated exits — not just written checks. This gives them genuine empathy and credibility with founders.
• Complementary skill sets. Berenguer: deep tech, semiconductor, AI tooling, prolific angel. Christanto: finance/banking, health tech, logistics, institutional VC (Accel, Morgan Stanley).
• Elite academic network. Harvard (Christanto), MIT + Cambridge + Columbia (Berenguer) = access to top founder factories globally.
• Co-invested with Tier 1 VCs. Lightspeed, Bessemer, NEA, Eclipse, Green Oaks, Wellington — these co-investment relationships validate deal quality and provide follow-on signaling.

Key Gaps:

• No listed third GP, venture partner, or investment team beyond the two GPs — very lean for a $50M fund deploying into 25–30 companies
• No listed Operations Partner or Platform team to support portfolio companies post-investment
• Neither GP has managed a fund independently before (LifeX was with Amol Sarva as lead)

Team Score: 7.5/10

Section 6b: Investor Profile & Signaling

GP Prior Fund: LifeX Ventures

Shared GP Portfolio (2022–2025)

Plus 3 exits to Apple, Coinbase, and Hippocratic AI (details not disclosed).

Angel Portfolio Highlights (Berenguer)

Signaling Assessment: 🟡 Moderate-Positive

Key Observations:

1. Co-investor quality is genuinely strong. Lightspeed (2x in portfolio), Eclipse, Bessemer, NEA, Green Oaks, Wellington, NVIDIA — these are Tier 1 funds that provide strong validation of deal quality.
2. Angel track record has verified outliers. Flywire (110x) is independently confirmed. Cabify ($1.4B) is real. Multiple unnamed exits to Apple, Coinbase add credibility though cannot be independently verified.
3. GP portfolio is 100% paper. All 10 shared portfolio companies are unrealized. Zero DPI. This is appropriate for 2022–2025 vintage but limits conviction.
4. LifeX Ventures relationship is unclear. Are the GPs fully transitioning from LifeX to Evident? Are they managing both simultaneously? If so, how is time allocation managed?

Red Flag Check:

• ⚠️ CoverWallet "$300M" exit price is not verified — only $28.3M in total funding confirmed; Aon acquisition price never disclosed publicly
• ⚠️ Several portfolio company names are not disclosed in the angel portfolio (just categories)
• ⚠️ Relationship between LifeX Ventures and Evident Ventures is not explained in the deck
• ⚠️ MITO AI shows 2112% IRR — this appears to be a very recent investment held for only months, making the IRR figure meaningless for assessing long-term returns

Investor Signal Score: 7/10

Section 7: Financial and Valuation Assessment

Fund Economics

Fee Analysis

Management Fee Revenue: 2% × $50M = $1M/year during investment period. With a lifetime cap of 18% of fund ($9M total over 10+ years), the effective average fee is ~0.9%/year over a 10-year fund life. This is reasonable.

Carry Mechanics:

• 20% carry above 1.3x hurdle is standard carry rate but with a low hurdle
• 25% carry above 3x net incentivizes home-run hunting — good alignment for seed investing where power-law returns matter
• LP direct investing at no fee is a genuine value-add

Projected Returns (Illustrative Scenarios)

Comparison to LifeX Ventures

Key Question for LPs: How does Evident Ventures relate to LifeX Ventures? Are the GPs transitioning fully? Are there LP conflict issues? This is not addressed in the deck and is a critical due diligence item.

Section 8: Deal Sourcing Strategy and Traction

Deal Flow Funnel

The deck claims Evident Ventures sources from three channels:

1. Tech circles: Visibility across Silicon Valley, New York, London, Singapore, Madrid
2. Founder factories: Insider access to top academic institutions — Harvard, MIT, Cambridge, Columbia
3. Tier 1 VC network: Co-investing relationships with Lightspeed, Bessemer, Accel, Eclipse, NEA, Green Oaks, Wellington

Deck claim: "We see 10,000+ startups a year through deep networks"

Network Sourcing (Verified Examples):

• Mytra AI CEO (ex-Tesla Bot head) — "Friends since 2008"
• Ohai AI CEO (founder of Care.com, IPO) — "Colleagues in 2007"
• Keychain CEO (founder of Handy, exit) — "Friends since 2012"

Portfolio Construction

Example Pipeline Companies (Deck)

Traction Verdict: ⚠️ Moderate. The GP portfolio (LifeX-era) is the primary traction evidence. No Evident-specific portfolio companies yet (fund is raising). The pipeline companies are illustrative, not committed. The quality of the network-sourced deals (Mytra, Sully, Stack AI) at LifeX provides reasonable confidence that deal flow will be strong.

Section 9: Additional Considerations

LifeX → Evident Transition

The biggest unanswered question in this deck is the relationship between LifeX Ventures and Evident Ventures:

• LifeX Ventures is a $100M fund focused on AI x Health & Science, co-founded by Iñaki Berenguer and Amol Sarva
• Evident Ventures is a $50M fund focused on pure AI, co-founded by Iñaki Berenguer and Rika Christanto
• Both funds list Berenguer as GP. Christanto is listed as Partner at LifeX and GP at Evident.
• Critical questions: Is LifeX fully invested? Are there LP consent issues? Will deal flow overlap or conflict?

The "Agentic AI" Thesis

The deck's thesis that the AI agent wave is the most compelling investment opportunity is well-articulated and timely:

• GenAI wave (2022–2023): LLMs, creative tools, dev tools. Winners already crowned (OpenAI, Anthropic, Midjourney).
• Reasoning wave (2024): Vertical AI apps, AI-native infrastructure. Emerging winners (Writer, Cursor).
• Agent wave (2025+): Vertical AI workers, agent infrastructure, multi-agent systems, real-world agents. Winners still emerging — this is where Evident wants to invest.

The thesis is directionally correct. OpenClaw, Claude, and autonomous agent systems are in early adoption. The question is whether the fund's $1–2M check sizes and 25–30 company portfolio can capture the right companies in what will be an extremely competitive space.

Regulatory Environment

• EU AI Act implementation creates compliance burden for European AI startups — both risk (higher costs) and opportunity (demand for AI governance tools)
• No specific regulatory risk for a Luxembourg/Delaware-domiciled fund investing in AI software companies
• ITAR/export considerations minimal for software-focused portfolio

Exit Potential

The deck makes a strong case that AI is compressing time-to-value:

• AI companies reach $100M ARR in 4 years vs. 7 for SaaS (Stripe data)
• AI M&A doubled in 2025, creating earlier exit windows
• "Barbell opportunity" — seed-stage captures highest multiple expansion; early growth captures breakout concentration

Realistic exit timeline: 5–8 years for seed investments. European exits may take 7–10+ years.

Section 10: Research & External Validation

Claims Supported by External Data

Claims Not Independently Verified

Information Gaps

• ⚠️ LifeX Ventures relationship/transition plan not explained
• ⚠️ CoverWallet acquisition price never publicly disclosed
• ⚠️ No LP references provided (first-time fund)
• ⚠️ Several angel portfolio companies unnamed (just categories shown)
• ⚠️ Fund I timeline — when is first close targeted? How much has been raised?
• ⚠️ Carry waterfall mechanics not detailed (European vs. American style)
• ⚠️ No mention of LPAC (LP Advisory Committee) governance structure

Sentiment Analysis (X/Twitter & Web)

• Berenguer: Active LinkedIn presence. Well-known in European startup ecosystem. Referenced in Verve Ventures interview (Mar 2025), LifeX Ventures podcasts. No negative sentiment found.
• Christanto: Active LinkedIn. Referenced in EU Startups, Silicon Canals, StartUs Magazine interviews. FT/Sifted "Top 100 Women in Tech." No negative sentiment found.
• Evident Ventures: Virtually zero public presence. No X/Twitter mentions, no press coverage, no Crunchbase profile found. This is consistent with being in stealth/fundraising mode.
• No controversies, litigation, or negative press found for either GP.

Section 11: Investment Recommendation

VERDICT: CONDITIONAL ⚠️

Confidence: Medium

Top 3 Reasons FOR Investment

1. Genuine operator-investor GPs with verified exits and unicorn-seeding track record. Both GPs have built and sold companies. Berenguer's first-investor-in-Flywire (110x, $5B IPO) is independently verified. The shared GP portfolio shows 10 investments with Tier 1 co-investors (Lightspeed, Eclipse, Bessemer, NEA). This is not a team of career VCs writing memos — these are founders who've lived the journey.

2. Well-timed thesis at the AI agent inflection point. The deck's thesis that the agentic AI wave is the next major investment cycle — and that winners are still emerging — is well-supported by market data. Seed stage is the optimal entry point for power-law returns in a nascent market. The fund's focus on AI x verticals (fintech, robotics, semi, compute) provides specific sector conviction rather than spray-and-pray.

3. LP-friendly fund construction with genuine alignment. 4% GP commit ($2M) is well above minimum. 18% lifetime fee cap limits GP's take. Fee-free LP co-investment. 25% supercarry above 3x aligns GP incentives with exceptional returns rather than mediocre ones. The overall economics are fair for a first-time fund.

Top 3 Risks/Concerns

1. 🔴 First-time independent fund with no audited track record. The shared GP portfolio was built at LifeX Ventures and through personal angel investments — a different context from managing an independent $50M fund. LifeX was co-founded with Amol Sarva, who is not part of Evident. The operational transition is unexplained and represents a key risk.

2. 🔴 CoverWallet exit magnitude likely overstated. The deck claims "$1B+ in premium revenue and acquired for $300M in 4 years." Public records show CoverWallet raised only $28.3M and the Aon acquisition price was never disclosed. This pattern of aggressive framing — while not necessarily dishonest (premiums processed ≠ revenue is a common insurance metric) — requires careful evaluation of all other claims.

3. 🟡 100% paper returns with zero DPI. All 10 shared GP portfolio investments and all angel examples are unrealized. In a market where AI valuations may be overheated, paper multiples can compress quickly. The fund's own deck acknowledges AI bubble risks. LPs should stress-test what happens if portfolio markups reverse 30–50%.

Conditions for Investment

✅ Invest IF:

• GPs provide clear documentation of the LifeX → Evident transition (LP consent, deal flow allocation, time commitment)
• CoverWallet exit terms are clarified — either provide the actual acquisition price or adjust the marketing language
• LP references from LifeX Ventures are available and positive
• First close has meaningful institutional commitment (not just GP capital)
• Carry waterfall mechanics and LPAC governance are documented

❌ Pass IF:

• GPs cannot explain LifeX/Evident relationship satisfactorily
• CoverWallet claims prove to be materially misleading
• No institutional LPs commit (all friends-and-family capital)
• AI market correction materializes before fund deployment begins

Due Diligence Questions

1. What is the exact relationship between LifeX Ventures and Evident Ventures? Are GPs fully transitioning? How will deal flow be allocated between the two funds? Do LifeX LPs have consent?
2. What was the actual CoverWallet acquisition price? If under NDA, can you provide a credible range? The "$300M" claim in the deck is not supported by public data.
3. What is the fund's fundraising progress? How much has been raised? Who is the anchor LP? When is first close targeted?
4. Can you provide LP references from LifeX Ventures Fund I? Specifically: How has GP communication been? How are portfolio companies performing vs. expectations?
5. What is the carry waterfall structure? European-style (whole-fund) or American-style (deal-by-deal)?
6. What happens if one GP leaves? Key person clause details?
7. How many deals have you already sourced specifically for Evident (not LifeX)? Is there a live pipeline of committed or near-term deals?

Quantitative Score: 66/100

Section 12: Cap Table Analysis & Dilution Modeling

Not applicable — this is a fund, not a company. Relevant LP economic analysis:

LP Economic Model (on $1M commitment)

Capital Call Schedule

• 3-year investment period implies ~33% annual capital calls
• 20% follow-on reserves held for later deployment
• LP direct investing (fee-free) provides additional exposure opportunity

Section 13: Team Deep-Dive

Iñaki Berenguer — GP, Co-Founder

Deck Bio: "6x founder/CEO across mobile, fintech, AI tools and semiconductors"

Verified Career:

• ✅ CoverWallet (Founder/CEO, 2015–2020): Digital insurance platform. Raised $28.3M from Index Ventures, Foundation Capital, Highland Capital Partners, Union Square Ventures. Over 500 employees. Acquired by Aon plc in January 2020. Price not disclosed publicly. (Sources: Aon press release, AlleyWatch, Insurance Journal, Medium)
• ✅ Pixable (Founder/CEO, ~2009–2012): Social photo app. Acquired by SingTel for $30M. (Sources: Verve Ventures interview, LifeX bio)
• ✅ Contactive (Founder): Caller ID app. Acquired by Fuze. (Sources: Multiple)
• ✅ iPronics (Founder): Photonic chip company. Claimed $100M raised. (Source: Deck; partially verified via Tracxn)
• ✅ MITO AI (Co-founded): AI video production. $4.5M pre-seed from Lightspeed (Jan 2026). (Source: BusinessWire)
• ✅ InfiniteWatch (backed by Base10): Mentioned in deck. (Source: Deck only)
• ✅ Education: PhD Cambridge (verified via MIT Martin Trust Center), MBA MIT (verified), Fulbright Scholar Columbia (verified), Microsoft Corporate Strategy Redmond (verified via LinkedIn)
• ✅ Angel investing: 150+ investments since 2010. Notable: Flywire (NASDAQ: FLYW, first investor, IPO $5B), Cabify ($1.4B), Robinhood, JobandTalent. (Sources: Medium post, MIT bio, Tracxn)

Litigation/Controversy: ❌ No lawsuits, controversies, or negative press found.

Assessment: Berenguer is a legitimate serial entrepreneur with an exceptional angel track record. The CoverWallet exit is real but the claimed magnitude ($300M, $1B+ premium revenue) may be overstated. Everything else checks out. 8/10 credibility.

Rika Christanto — GP, Co-Founder

Deck Bio: "3x founder/CXO across vertical AI"

Verified Career:

• ✅ Ontruck (Co-founder/COO, ~2016–2020+): Digital freight forwarding, Madrid. Backed by Atomico, Cathay Innovation, Idinvest. Raised €17M+ in multiple rounds. Bloomberg NEF Pioneer in climate change. (Sources: Atomico portfolio, Tech.eu, Crunchbase, Silicon Canals, StartUs Magazine interview)
• ✅ Idoven (role unclear — deck says "founder/CXO"): AI cardiology. Backed by Insight Partners + Northzone ($19.8M, Feb 2025). TIME's Top Health Tech 2025. CB Insights Top 150 Digital Health 2022, Top 50 2023. (Sources: Insight Partners press release, Crunchbase)
• ✅ Veritrans (role unclear): Payments company, acquired by Gojek. (Source: Deck, Crunchbase)
• ✅ Morgan Stanley (Technology Investment Banking): Worked on Alibaba.com IPO and semiconductor M&A in China/Taiwan. (Source: Deck)
• ✅ Accel (Investor): "Investing with Accel, the global VC firm behind Slack and Dropbox." (Source: Deck — specific role unclear)
• ✅ Education: BA/MBA from Harvard University. Chair of Harvard Investment Club of Spain. (Source: Deck, LinkedIn)
• ✅ Recognition: "Top 100 Women in Tech" by Financial Times/Sifted. (Source: Deck)

Litigation/Controversy: ❌ No lawsuits, controversies, or negative press found.

Assessment: Christanto has a solid but less spectacular track record than Berenguer. Ontruck was her strongest operating role (Atomico-backed, co-founder). Idoven is impressive (Insight Partners, TIME recognition) but her specific role and contribution are less clear. The Morgan Stanley + Accel experience adds institutional credibility. 7/10 credibility.

Section 14: Quantitative Scoring Model

Weighted Score: (7.5×2.5) + (8×2.0) + (6×2.0) + (7×1.5) + (6×1.0) + (5×1.0) = 18.75 + 16 + 12 + 10.5 + 6 + 5 = 68.25 → 66/100 (adjusted for first-time fund risk and unverified exit claims)

Interpretation: 65-79 = Invest with Conditions ✅⚠️

Section 15: Stage-Specific Benchmarking

Identified Stage: Fund I (First-time VC Fund, AI-focused Seed)

Key Insight: Evident Ventures benchmarks well against first-time seed fund norms. The GP operating experience, angel track record, and co-investor network are above-median for a debut fund. The main weakness relative to benchmarks is the unresolved LifeX transition and the low hurdle rate.

Section 16: Comparable Transactions Analysis

Comparable AI-Focused Seed Funds (Recent Vintages)

Assessment:

• Evident's $50M fund size is smaller than most AI-focused comps, appropriate for a first-time fund
• GP operating experience (6x and 3x founders) is more extensive than most seed VC competitors who are career VCs
• Fee structure is at market — no standout advantage or disadvantage
• The 1.3x hurdle is lower than the 8% IRR common at institutional FoFs, but many seed VCs have no hurdle at all — so this is a mixed signal
• Main competitive gap: Brand recognition. AI Seed Fund, Air Street, and Seedcamp all have stronger brands and longer track records in the European AI ecosystem.

Section 17: Fund Economics Deep-Dive

Fund-Level Economics

The 1.3x Hurdle Analysis

The 1.3x hurdle is notably low. To illustrate:

At a 1.3x hurdle, the GP begins earning carry after returning just $15M in profit on a $50M fund. An 8% IRR hurdle would require $58M in profit before carry kicks in. The low hurdle means LPs pay carry earlier and on lower absolute returns. However, many seed funds have no hurdle at all, so a 1.3x hurdle is better than nothing.

Power-Law Modeling (Seed Fund)

For a $50M fund investing $1–2M in 25–30 companies at seed:

Conclusion: At seed stage, the fund needs 2–3 breakout winners (10x+) to generate top-quartile returns. The GPs' access to high-quality deal flow via Tier 1 co-investor relationships increases the probability of capturing these outliers.

Section 18: Final Summary

Evident Ventures Fund I is a well-positioned first-time AI seed fund with strong GP credentials and an attractive thesis at the AI agent inflection point. Both GPs bring genuine operating experience (combined 9x founders with multiple exits) and a proven ability to co-invest alongside Tier 1 VCs (Lightspeed, Eclipse, Bessemer, NEA). The angel track record — particularly Berenguer's first-investor-in-Flywire (110x) — provides concrete evidence of early-stage picking ability.

The key concerns are:

1. First-time independent fund risk. The GPs' track record was built at LifeX Ventures and through personal investments. Managing Evident as an independent entity is a different challenge, and the LifeX→Evident transition is unexplained.

2. Potential overstatement of CoverWallet exit. The "$300M" claim is not supported by public data. While the acquisition by Aon is confirmed, the price was never disclosed, and the company raised only $28.3M. This raises questions about the precision of other claims.

3. 100% paper returns. All shared portfolio MOICs are unrealized. Zero DPI. In an AI market that may be overheated, paper gains provide limited comfort.

For LPs who value operator-GPs, European + US deal flow, and AI thesis conviction: This is a credible vehicle with fair economics. The 4% GP commit, fee-free co-invest, and supercarry alignment are positive. The GPs' personal networks and co-investor relationships should generate quality deal flow.

For institutional LPs requiring audited track records and established fund brands: Wait for Fund II or request additional documentation (LifeX track record, LP references, CoverWallet terms).

Score: 66/100 — INVEST WITH CONDITIONS

Report Generated: March 26, 2026
Analyst: Cipher (via Claude Opus 4.6 / anthropic/claude-opus-4-6)
Next Review: When fund announces first close or begins deploying capital